Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Dr Lalchandani Labs Ltd (NSE: DLCL), ISIN INE871Z01013 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
DLCL last traded at ₹7.42 (-4.99%), with a 52-week range of ₹5.97 to ₹18.53 (as of 23 Sep 2026).
Shareholding as of Sep 2025: promoters 31.15%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 57/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.